Repare Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	138	308	617	880	1,261	-
Market Cap Growth	-52.02%	-50.18%	-29.87%	-30.20%	-	-
Enterprise Value	-97	87	279	546	931	-94
PE Ratio	-	-3.28	-21.25	-8.23	-23.61	-
PS Ratio	1.41	6.02	4.68	115.82	9341.04	-
PB Ratio	0.59	1.45	2.21	3.05	4.40	-
P/FCF Ratio	-2.34	-2.38	-2204.48	-10.07	-151.55	-
P/OCF Ratio	-2.38	-2.42	1916.94	-10.26	-207.27	-
EV/Sales Ratio	-0.36	1.71	2.11	71.79	6897.21	-
EV/EBITDA Ratio	0.66	-0.88	-28.69	-5.18	-17.58	3.61
EV/EBIT Ratio	0.61	-0.85	-20.05	-5.02	-17.01	3.48
EV/FCF Ratio	0.42	-0.68	-995.50	-6.24	-111.90	4.76
Debt / Equity Ratio	0.01	0.02	0.02	0.03	0.01	-0.02
Debt / EBITDA Ratio	-0.05	-0.03	-0.56	-0.07	-0.08	-0.04
Debt / FCF Ratio	-0.03	-0.03	-19.39	-0.08	-0.48	-0.05
Quick Ratio	7.86	5.84	4.43	9.76	30.70	22.84
Current Ratio	8.33	6.24	4.50	10.02	31.47	23.22
Asset Turnover	0.35	0.17	0.37	0.02	0	0
Return on Equity (ROE)	-19.80%	-39.80%	-10.90%	-41.90%	-25.30%	79.40%
Return on Assets (ROA)	-16.50%	-31.80%	-8.20%	-32.30%	-17.80%	-46.70%
Return on Capital (ROIC)	-30.13%	-53.93%	-6.95%	-36.74%	-18.67%	58.53%
Earnings Yield	-33.23%	-30.50%	-4.71%	-12.15%	-4.24%	-
FCF Yield	-61.74%	-41.98%	-0.05%	-9.93%	-0.66%	-
Buyback Yield / Dilution	-4.72%	-0.41%	-10.85%	-88.66%	-1211.56%	-
Total Shareholder Return	-4.72%	-0.41%	-10.85%	-88.66%	-1211.56%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).